Home / Omeprazole / Canada
CA ATC A02BC01 · updated 2 Nov 2026
Omeprazole shortage in Canada
Is there an Omeprazole shortage in Canada?
Yes. As of 2 Nov 2026, 13 Omeprazole products are reported short in Canada, the first since 14 Dec 2018. The company estimate for the return is 4 Dec 2026 (latest 22 Jan 2027). Main reason: manufacturing problem.
Also short in Italy, Spain, Czechia, Norway, Sweden, Japan, New Zealand. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | LOSEC 10 MG (2 x 15) discontinuation | ASTRAZENECA CANADA INC | 14 Dec 2018 | not given | Other Other (Please describe in comments) |
| CA | PMS-OMEPRAZOLE (100) | PHARMASCIENCE INC | 28 Feb 2019 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP-OMEPRAZOLE DR (100) | JAMP PHARMA CORPORATION | 19 Jan 2024 | 22 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP-OMEPRAZOLE DR (2x14) | JAMP PHARMA CORPORATION | 19 Jan 2024 | 22 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP-OMEPRAZOLE DR (500) | JAMP PHARMA CORPORATION | 19 Jan 2024 | 4 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | OMEPRAZOLE MAGNESIUM DELAYED RELEASE TABLETS (100) | ACCORD HEALTHCARE INC | 12 Apr 2024 | not given | Manufacturing problem Requirements related to complying with good manufacturing practices |
| CA | NAT-OMEPRAZOLE DR (100 BTL) | NATCO PHARMA (CANADA) INC | 13 Jun 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | BIO-OMEPRAZOLE (100) | BIOMED PHARMA | 17 Oct 2024 | not given | Manufacturing problem Requirements related to complying with good manufacturing practices |
| CA | TEVA-OMEPRAZOLE (100) | TEVA CANADA LIMITED | 7 Nov 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | OMEPRAZOLE MAGNESIUM DELAYED RELEASE TABLETS (100) | SANIS HEALTH INC | 18 Nov 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-OMEPRAZOLE (100) | TEVA CANADA LIMITED | 27 Aug 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-OMEPRAZOLE (500) | TEVA CANADA LIMITED | 3 Dec 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-OMEPRAZOLE (100 BTL) | APOTEX INC | 8 Sep 2026 | 11 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.